MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

AngioDynamics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

9.65 2.55

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

9.04

Max

9.67

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2.7M

-11M

Pardavimai

1.9M

73M

Pelnas, tenkantis vienai akcijai

-0.04

Pelno marža

-14.741

Darbuotojai

748

EBITDA

3.8M

1.8M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+63.26% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-04-02

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

107M

384M

Ankstesnė atidarymo kaina

7.1

Ankstesnė uždarymo kaina

9.65

Naujienos nuotaikos

By Acuity

31%

69%

86 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

AngioDynamics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2024-12-09 15:23; UTC

Pagrindinės rinkos jėgos

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

2024-12-09 15:20; UTC

Pagrindinės rinkos jėgos

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

2024-04-04 14:56; UTC

Uždarbis
Pagrindinės rinkos jėgos

AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Akcijų palyginimas

Kainos pokytis

AngioDynamics Inc Prognozė

Kainos tikslas

By TipRanks

63.26% į viršų

12 mėnesių prognozė

Vidutinis 15.33 USD  63.26%

Aukščiausias 16 USD

Žemiausias 15 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines AngioDynamics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

9.35 / 9.87Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

86 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.